This post was originally published on this site
Rapid developments in healthcare technology and growing government spending on biotechnology and pharmaceutical R&D are anticipated to drive the nanotech sector’s growth. The global nanotechnology market is expected to reach $126.8 billion by 2027, growing at a 12.9% CAGR.
Given the accelerating growth of the nanotechnology market, we think it may be prudent to bet on fundamentally strong nanotech companies Thermo Fisher Scientific Inc. (NYSE:TMO) and Onto Innovations Inc. (ONTO), which have the potential to deliver huge returns to investors in the coming months.
